3 results
Primary: To determine whether treatment with BKM120 plus fulvestrant prolongs PFS based on local investigator assessment compared to treatment with placebo plus fulvestrant for all patients regardless of PI3K pathway activation status (unkown status…
Primaryo To evaluate the effects of oliceridine following IV bolus dose administration on neurocognitive functioning, when compared to morphine and placeboSecondaryo To evaluate the effects of oliceridine following IV bolus dose administration on…
Primary Efficacy Objective (Blinded Treatment Period)• To demonstrate the efficacy of rilzabrutinib versus placebo in participants with refractory/relapsed ITP, based on the durability of platelet response during the last12 weeks of the 24-week…